Quarterly Report

Alaunos Therapeutics, Inc. Filed 2017-11-06 Acc 0001193125-17-334249

Documents 1

2018-05-10 10-Q Quarterly Report
2017-11-09 4 Chief Executive Officer bought 6,440 shares at $4.68 ($30,139)
2017-11-09 4 EVP and Chief Business Officer bought 4,270 shares at $4.68 ($19,984)
2017-11-06 8-K Results of operations · Executive or director change
2017-11-06 10-Q Quarterly Report
2017-11-01 4 Options or other derivatives
2017-07-31 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d464223d10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…